Traders sold shares of UnitedHealth Group Incorporated (NYSE:UNH) on strength during trading on Thursday following insider selling activity. $81.70 million flowed into the stock on the tick-up and $116.96 million flowed out of the stock on the tick-down, for a money net flow of $35.26 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $1.27 for the day and closed at $211.13Specifically, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the sale, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders sold a total of 72,606 shares of company stock worth $14,308,783 in the last three months. Company insiders own 0.89% of the company’s stock.

A number of analysts recently issued reports on UNH shares. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley lifted their target price on UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research report on Wednesday, October 18th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Finally, Leerink Swann reaffirmed a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $216.65.

The firm has a market capitalization of $204,130.00, a price-to-earnings ratio of 22.05, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business posted $2.17 earnings per share. equities analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.43%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.

A number of institutional investors and hedge funds have recently modified their holdings of UNH. Ameriprise Financial Inc. boosted its position in shares of UnitedHealth Group by 29.9% during the 1st quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock worth $546,574,000 after purchasing an additional 766,573 shares in the last quarter. Gerber Kawasaki Wealth & Investment Management bought a new position in shares of UnitedHealth Group during the 1st quarter worth about $227,000. Patriot Financial Group Insurance Agency LLC boosted its position in shares of UnitedHealth Group by 1,722.9% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after purchasing an additional 603 shares in the last quarter. Toronto Dominion Bank boosted its position in shares of UnitedHealth Group by 43.8% during the 1st quarter. Toronto Dominion Bank now owns 299,729 shares of the healthcare conglomerate’s stock worth $49,171,000 after purchasing an additional 91,262 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its position in UnitedHealth Group by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after acquiring an additional 12 shares in the last quarter. 86.00% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This report was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/11/18/traders-sell-unitedhealth-group-incorporated-unh-on-strength-following-insider-selling.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.